Method of inhibiting inflammatory response

作者: Juliann G. Kiang , Edward T. Wei

DOI:

关键词:

摘要: Many malignant neoplasias are treated by radiation therapy which can result in painful inflammation of the covering skin and/or mucosal membranes. Similarly, disorder patients receiving U.V. treatment may experience an inflammatory response. Certain neuropeptides have been discovered to unusual properties preventing, or inhibiting, edema and protein extravasation membrane injuries due thermal assault exposure trauma noxious agents. A method for inhibiting response membranes a patient is provided therapeutically effective amount neuropeptide, such as Corticotropin Releasing Factor ("CRF") its analogs, administered.

参考文章(7)
Donald E. Ayer, Carl A. Schlagel, Gordon L. Flynn, Anti-inflammatory steroid ,(1975)
Nancy M. Lee, Horace H. Loh, Therapeutic uses of dynorphin ,(1981)
John R. Marvel, David T. Rovee, James A. Mezick, Topical anti-inflammatory drug therapy ,(1977)
Catherine L. Rivier, Wylie W. Vale, Jean E. F. Rivier, Joachim Spiess, CRF And analogs ,(1982)
Wylie W. Vale, Joachim Spiess, Jean E. F. Rivier, Rcrf and analogs ,(1984)
Edward T. Wei, Jaw-Kang Chang, Nancy M. Lee, Method for controlling blood pressure ,(1983)